JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.
You may also be interested in...
In this first of two roundups, Medtech Insight highlights new product launches and technologies showcased at the annual AAOS conference by three major orthopedics players and medical data company Canary Medical.
Quentin Blackford, who recently became iRhythm’s CEO after serving as Dexcom’s chief operating officer, talked to Medtech Insight about the challenges and opportunities in the emerging remote cardiac monitoring market.
The “President’s Winter Plan” to fight the new variant includes mailing out free COVID-19 take-home tests to Americans who ask for it. AdvaMed says it will encourage manufacturers to keep producing tests.